Bullish Case: BMI's flat term structure with Helium IV ~3% above market implies options are modestly rich, favoring premium sellers, but the tape supports upside: call volume runs 71% above puts, bullish risk exceeds bearish risk by 14%, and the return-density surface concentrates likelihood in small positive returns. Mean-reversion from a -27% annual drawdown toward the $135 Helium-density mode is the base upside path.

Bearish Case: P/B of 7.3 leaves little valuation cushion after a two-year -37% collapse; the price-density PDFs show fat left tails down to $105-115, and Helium's forecast correlation near zero means model conviction is weak. Thin 29th-percentile liquidity amplifies gap risk around the January earnings cycle; any guidance miss could re-rate BMI back toward $120 quickly.

Potential Outcomes:

1. Range $122-135 (45%) — densities peak at $125-130; flat term structure and quiet tape favor grind.
2. Upside to $138-148 (25%) — call flow (71% > puts), +14% bullish skew, mean reversion from -27% yearly.
3. Downside to $115-122 (20%) — fat left PDF tail, high P/B, thin liquidity gap risk into earnings.
4. Vol spike then fade (10%) — Helium IV 3% above market; November 140C shows market ask $5.40 vs model $4.92, sell overpriced wings.

Oracle: short Nov-20 140C against 135C where market exceeds Helium theo.

October 21, 2026